[BidClub_]

PERSON DIRECTORY

David Sacks

Host of All-In. David Sacks appears in 104 indexed conversations across All-In, The a16z Show. This directory brings every appearance, source, TL;DR, digest, and transcript into one searchable feed.

104 EPISODES2 SHOWS
3 episodes3 active
Language
The a16z ShowEN · 77 min

Sacks, Andreessen & Horowitz: How America Wins the AI Race Against China

David SacksMarc AndreessenBen HorowitzErik Torenberg

Sacks and Andreessen argue that US AI leadership requires permissionless innovation, infrastructure, energy, and exports, while fragmented state rules and model licensing could make incumbency the moat.Their near-term thesis rests on specialized models, broad consumer adoption, open-source freedom, and grid flexibility, but China’s lead in open source and the unresolved power bottleneck remain material risks.

All-InEN · 127 min

Tariffs, Trump's Economic Endgame, Market Chaos, Bitcoin Reserve, CoreWeave IPO

Chamath PalihapitiyaJason CalacanisDavid SacksDavid FriedbergJoe Lonsdale

The panel frames tariffs as a border lever, industrial-policy experiment, and attempt to rebase dollar dependence, with predictable rates favoring commodities and sectors that have domestic substitutes.CoreWeave shows the other side of the AI infrastructure trade: $1.9 billion of 2024 revenue and 250,000 Nvidia GPUs alongside almost $8 billion of debt, nearly $1 billion of losses, and roughly 60% Microsoft concentration.

All-InEN · 97 min

DOGE vs USAID, Crypto Framework, Google's $75B AI Spend, US Sovereign Wealth Fund, GLP-1s

Chamath PalihapitiyaJason CalacanisDavid SacksDavid FriedbergAntonio Gracias

Crypto’s policy path is stablecoin legislation followed by a FIT21-style market-structure bill, with Sacks citing alignment among all four relevant committee chairs and passage within several months as plausible.Google’s $75B 2025 capex plan looks like a utilization and ROIC test: a 20% return plus six-year amortization requires roughly $27B in incremental annual operating profit.A US sovereign wealth fund remains divided between strategic reinvestment and disciplined asset sales, while GLP-1 benefits and muscle and bone-density loss remain unresolved.